Great article this morning talking about the Anti-sense program and the current 18 drugs in development and how how in the upcoming months news concerning ISIS drugs will drive this stock much higher. PLUS ISIS wants to go it alone but what happens if they get the right offer for this company. Big drug companies need this pipeline. It will take ISIS much longer to reap the benefits of these drugs without a huge sales force. Personally I am looking at somebody taking them out at maybe $80 a share and probably in the next 6 months and I may be too low in my estimate of the take out value! These are my thoughts only!
Why would the mngmt want to sell for "only" $80 when they will get there on their own within the next 18 mos. with such a strong pipeline? The founders are "in the clover" now and are only at the beginning of their RNA expertise paying off so, again, why take such a short-term (short sighted) gain after all the long term effort? It isn't as if they are out of ideas or molecules to bring forward.